McKesson Corporation
MCKNYSEHealthcare● Active
$768.32
$-7.34(-0.95%)
Market Cap$92.4B
P/E Ratio—
52W High$999
52W Low$637
McKesson Corporation (MCK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MCK · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
$11.69
Est. $11.56 · +1.1%
Revenue
$96.30B
Est. $101.3B · -5.0%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue🔥 5-Quarter EPS Beat Streak
MCK reports quarterly as a NYSE-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.36
Rev. $5.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.36
Rev. Est.$5.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | $9.63 | — | — | — | $104.0B | — |
| ▲ Q2 FY2026 | May 7, 2026 | $11.56 | $11.69 | +1.1% | $96.30B | $101.3B | -5.0% |
| ▲ Q1 FY2026 | Feb 4, 2026 | $9.17 | $9.34 | +1.9% | $106.2B | $105.8B | +0.3% |
| ▲ Q4 FY2025 | Nov 5, 2025 | $9.03 | $9.86 | +9.2% | $103.2B | $104.1B | -0.9% |
| ▲ Q3 FY2025 | Aug 6, 2025 | $8.14 | $8.26 | +1.5% | $97.83B | $96.18B | +1.7% |
| ▲ Q2 FY2025 | May 8, 2025 | $9.83 | $10.12 | +3.0% | $90.82B | $94.30B | -3.7% |
| ▼ Q1 FY2025 | Feb 5, 2025 | $8.60 | $8.03 | -6.6% | $95.29B | $96.05B | -0.8% |
| ▲ Q4 FY2024 | Nov 6, 2024 | $6.88 | $7.07 | +2.8% | $93.65B | $89.33B | +4.8% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
$9.63
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
$11.69
EPS Est.
$11.56
EPS Surpr.
+1.1%
Revenue
$96.30B
Q1 FY2026
Feb 4, 2026Beat
EPS Actual
$9.34
EPS Est.
$9.17
EPS Surpr.
+1.9%
Revenue
$106.2B
Q4 FY2025
Nov 5, 2025Beat
EPS Actual
$9.86
EPS Est.
$9.03
EPS Surpr.
+9.2%
Revenue
$103.2B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
$8.26
EPS Est.
$8.14
EPS Surpr.
+1.5%
Revenue
$97.83B
Q2 FY2025
May 8, 2025Beat
EPS Actual
$10.12
EPS Est.
$9.83
EPS Surpr.
+3.0%
Revenue
$90.82B
Q1 FY2025
Feb 5, 2025Miss
EPS Actual
$8.03
EPS Est.
$8.60
EPS Surpr.
-6.6%
Revenue
$95.29B
Q4 FY2024
Nov 6, 2024Beat
EPS Actual
$7.07
EPS Est.
$6.88
EPS Surpr.
+2.8%
Revenue
$93.65B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $17.62 | $17.98 | $18.47 | 3 |
| Q4 FY2029 | $16.27 | $16.60 | $17.05 | 3 |
| Q3 FY2029 | $14.57 | $14.86 | $15.26 | 6 |
| Q2 FY2029 | $14.40 | $14.69 | $15.09 | 3 |
| Q1 FY2029 | $16.72 | $17.06 | $17.52 | 3 |
| Q4 FY2028 | $14.97 | $15.27 | $15.68 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2030 | $133B | $135B | $138B | 4 |
| Q4 FY2029 | $139B | $142B | $145B | 4 |
| Q3 FY2029 | $137B | $139B | $142B | 7 |
| Q2 FY2029 | $131B | $133B | $136B | 4 |
| Q1 FY2029 | $116B | $118B | $121B | 4 |
| Q4 FY2028 | $128B | $130B | $132B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +1.1% | $743.67 | $754.76 | +1.49% |
| ▲ Q1 FY2026 | Feb 4, 2026 | +1.9% | $851.12 | $822.00 | -3.42% |
| ▲ Q4 FY2025 | Nov 5, 2025 | +9.2% | $841.67 | $844.26 | +0.31% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +1.5% | $709.49 | $703.76 | -0.81% |
| ▲ Q2 FY2025 | May 8, 2025 | +3.0% | $722.37 | $690.25 | -4.45% |
| ▼ Q1 FY2025 | Feb 5, 2025 | -6.6% | $603.32 | $606.90 | +0.59% |
| ▲ Q4 FY2024 | Nov 6, 2024 | +2.8% | $525.28 | $549.31 | +4.57% |
| ▲ Q3 FY2024 | Aug 7, 2024 | +9.3% | $614.32 | $617.51 | +0.52% |
Q2 FY2026+1.49%
Report Date
May 7, 2026
EPS Beat/Miss
+1.1%
Price Before
$743.67
Price After
$754.76
Q1 FY2026-3.42%
Report Date
Feb 4, 2026
EPS Beat/Miss
+1.9%
Price Before
$851.12
Price After
$822.00
Q4 FY2025+0.31%
Report Date
Nov 5, 2025
EPS Beat/Miss
+9.2%
Price Before
$841.67
Price After
$844.26
Q3 FY2025-0.81%
Report Date
Aug 6, 2025
EPS Beat/Miss
+1.5%
Price Before
$709.49
Price After
$703.76
Q2 FY2025-4.45%
Report Date
May 8, 2025
EPS Beat/Miss
+3.0%
Price Before
$722.37
Price After
$690.25
Q1 FY2025+0.59%
Report Date
Feb 5, 2025
EPS Beat/Miss
-6.6%
Price Before
$603.32
Price After
$606.90
Q4 FY2024+4.57%
Report Date
Nov 6, 2024
EPS Beat/Miss
+2.8%
Price Before
$525.28
Price After
$549.31
Q3 FY2024+0.52%
Report Date
Aug 7, 2024
EPS Beat/Miss
+9.3%
Price Before
$614.32
Price After
$617.51
Avg Beat Reaction-0.26%
Avg Miss Reaction+0.59%
Beat Rate7 / 8 quarters
Largest Move+4.57% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MCK ends December
McKesson Corporation (MCK) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $11.69 — beating the analyst consensus of $11.56 by +1.1%. MCK has beaten EPS estimates for 5 consecutive quarters. The next MCK earnings date is expected around September 1, 2026.
Each quarter, investors track MCK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MCK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MCK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MCK earnings · 5 questionsMcKesson Corporation's next earnings report is expected around September 1, 2026. MCK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MCK historically reports after market close (AMC).
MCK earnings datewhen is MCK earningsMCK next earnings datewhen does MCK report earningsMCK earnings calendar
▸ Source: FMP · McKesson Corporation SEC filings · US GAAP · McKesson Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026